Hyasynth Bio
is a biotechnology company that develops and commercializes cannabinoids for the healthcare industry... Read moreHyasynth Bio
is a biotechnology company that develops and commercializes cannabinoids for the healthcare industry... Read more
News
Dec 22, 2021
Benzinga
Hyasynth Bio: Organigram Invests Additional $2.5M In CBD Biotech Co Hyasynth, Wraps Up $10M Debenture Purchase Deal
Dec 22, 2021
MarketScreener
Hyasynth Bio: Organigram : Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company - Form 6-K
May 26, 2021
EIN Presswire
Press Release: Hyasynth Bio : Hyasynth announces production of >20 rare cannabinoids by fermentation & US patent grant on novel biosynthesis pathway
Oct 27, 2020
International Business Times
Hyasynth Bio: Organigram Dramatically Ups Its Investment Into Biosynthesized Cannabis Products
Oct 27, 2020
RTTNews
Hyasynth Bio: Organigram Invests Additional $2.5 Mln In Hyasynth Biologicals
Oct 23, 2020
News Break
Hyasynth Bio: Hyasynth completes key commercialization milestone for cannabinoid biosynthesis, receives $2.5 million payment | News Break
Oct 23, 2020
Benzinga
Hyasynth Bio: Organigram Invests In Hyasynth Biologicals, Parts Ways With Executives
Sep 29, 2020
CFN Media Group
Hyasynth Bio: Hyasynth first to market with CBD in global race to commercialize cannabinoids produced using microbial biosynthesis
May 22, 2019
New Cannabis Ventures
Hyasynth Bio: Early Mover Hyasynth Bio Aims to Deliver in the Cannabinoid Biosynthesis Space
Sep 13, 2018
PLANT
Hyasynth Bio: Organigram invests in biotech firm that produces cannabinoids in a lab
Hyasynth Bio Competitors
1
2
3
4
5
6
7
8
9
10